GOVERNOR'S AUTHORIZED REPRESENTATIVE: $1.8B Department of Homeland Security Grant

The contract is a $1.8 billion project grant from the Department of Homeland Security's Federal Emergency Management Agency (FEMA) to the 'Governor's Authorized Representative,' which is a state government official. The funding reimburses public entities and certain non-profits for emergency protective measures taken during the COVID-19 pandemic, such as emergency medical care, medical sheltering, and vaccine distribution. Since the recipient is a government entity, no publicly traded company directly benefits from this award. However, the spending may indirectly benefit companies that provide related goods and services—such as medical supplies, vaccines, and temporary shelters—but these are diffuse and not contract-specific. The contract period extends to 2026-09-30, indicating multi-year reimbursement activity. No related legislation in the provided HillSignal database directly authorizes or appropriates this specific grant; the grant appears to stem from existing FEMA authority under the Stafford Act and pandemic response appropriations. Without a direct public company beneficiary, the market impact is minimal, and no specific tickers or supply chain winners can be reliably identified. Historical patterns for large FEMA grants show that while aggregate government healthcare spending can boost sector ETFs, individual company stock movements are driven by specific procurement contracts, not reimbursements to state governments.